Feeling fine in general, allergy symptoms improved. C. T. Have been doing a lot schizandra better. Lisa L. So far, so good. Andy G. Felt congested, but improved. Richard R. Feeling fine. pregnancy herb no problems. roland h. feel ok as far as allergies. angel p. i felt relief after the treatment, and still feeling better. a. v. i feel schizandra ok, but have a little congestion. carlin r. feel better than before. art p. feel good - continue with sinusitis bob m. feeling moderate. gustavo m. much better. alejandro organ specific herb m. what patients said after more than two months all my symptoms seem to have gone. margareth z. for the first time after taking the treatment, i felt like my life was my own. after 20 years i was able to go out in traffic and high winds with little or no bad effects. i could even tolerate gas lawn mowers. i was able to walk around without huffing and puffing. pain in throat and lungs disappeared. getting air in lungs.

a recent study in japan indicates that b12 treatment helps in the growth and division of certain immune system cells.11 these cells function to prevent schizandra the immune system from over-reacting to allergens such as animals, mold, dust, and pollen. serotonin herb they are called suppressor cells or cd8+ lymphocytes. they “put the brakes on the immune system”. this medicationtm is a 21-day treatment of b12 lozenges sucked on twice daily. schizandra this medicationtm may help patients with hay fever by providing the patient’s suppressor cells with the sustained herb and elevated blood b12 level they need to grow and divide. it appears that by helping the immune system to become what it is genetically capable of becoming, this medicationtm turns at least some allergic people into non-allergic or moderately-allergic people.

all of the active b12 group reporting showed reduction in severity of symptoms ranging from 31% to 70%, while the placebo controls reported either no change schizandra or a worsening of symptoms. wilcoxon-rank of .002 for the end-points of sneezing, nasal congestion and runny nose; and p = .005 for ige reductions. in 1992, the above mentioned data from 1988 on were presented by dr. o''connor to the fda. the fda panel acknowledged the safety of the treatment. the panel seemed to be in agreement that the statistics herb indicated a significant reduction in ige and that a quantitative drop in symptoms was demonstrated. in 1992, belen anibarro, md, studied five children with asthma with metabisulfite intolerance confirmed by oral challenge testing. the test was repeated after premedication with 1.5 mg of oral cyanocobalamin. in four of the five patients treated, bronchospasm did not develop in the second metabisulfite challenge.6